T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
Status:
Terminated
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The hypothesis is to determine if a preparative regimen of busulfan, cyclophosphamide, and
antithymocyte globulin (ATG) plus allogeneic stem cell transplantation will be effective in
the treatment of immune deficiencies and histiocytic disorders.